An audit of the management of diabetic ketoacidosis at St Luke’s Hospital by Abela, Alexia-Giovanna et al.
6 Malta Medical Journal    Volume 20   Issue 02   June 2008
Alexia-Giovanna Abela, Caroline Jane Magri, Miguel Debono, 
Neville Calleja, Josanne Vassallo,  Joseph Azzopardi 
Original Article
An audit of the management of diabetic 
ketoacidosis at St Luke’s Hospital 
Abstract
Aim: To perform an audit of the protocol used in the 
management of patients with Diabetic Ketoacidosis, in St Lukes 
Hospital.
Methods: Patients admitted with ‘Diabetes Ketoacidosis’, 
between 14th August 2004 and 14th August 2005, were identified 
from the Admission book at the Accident and Emergency 
Department. Data obtained from patients’ medical records were 
collected according to a preset proforma. The criteria assessed 
by this audit included parameter monitoring, investigations 
performed, the type and amount of intravenous fluids given, 
the insulin regime and potassium supplements used.
Results: From a total of fifty six patients, forty seven 
files were traced, of which seventeen satisfied the criteria for 
Diabetic Ketoacidosis. Two were excluded and fifteen were 
analysed. In the population studied the mean age was 28 years 
with a male predominance of 60%. Ten patients suffered from 
Type 1 Diabetes whilst two patients had Type 2 Diabetes. Three 
other patients were newly diagnosed. Only one patient had 
all parameters checked according to protocol. In the majority 
of patients, fluids given in the first 22 hours, coincided with 
the amount of fluids stated in the protocol whilst 6/15 (40%) 
patients were administered the requested amount of insulin via 
infusion pump. With regards to potassium replacement, 13/15 
(87%) patients were started on potassium supplements at a later 
stage. The factors influencing the total time for conversion to 
a fixed insulin regime and the duration of stay in hospital were 
also analysed.
Conclusion: Deviations from the protocol were identified 
in parameter recording, the type of intravenous fluids given 
and the doses of insulin and potassium supplementation 
administered.  New Diabetic Ketoacidosis guidelines have now 
been developed. 
Introduction
Diabetic Ketoacidosis (DKA) is a state of uncontrolled 
catabolism associated with insulin deficiency, counter-
regulatory hormone excess and fluid depletion. It is the hallmark 
of Type 1 Diabetes (DM) and can be its mode of presentation. 
However, patients with Type 2 DM are also at risk of developing 
DKA during the catabolic stress of acute illness.1 Signs and 
symptoms of DKA include polyuria, polydipsia, lethargy, 
anorexia, hyperventilation, ketotic breath, dehydration, 
vomiting, abdominal pain and coma. Precipitants include 
infections, psychological stress, poor compliance with therapy, 
cerebrovascular accidents, alcohol/drug abuse, pancreatitis, 
pulmonary embolism, myocardial infarction, trauma and 
drugs.2  DKA continues to be an important cause of morbidity 
and mortality amongst patients with diabetes. Mortality rates 
in DKA, quoted at <5%, increase substantially with increasing 
age and concomitant life-threatening illnesses.3,4  DKA treatment 
outcomes are similar in both community and teaching hospitals, 
and do not vary with the level of expertise of the managing 
physician, so long as standard written therapeutic guidelines 
are followed.1 
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Patients admitted to St. Luke’s Hospital (SLH) were 
diagnosed with DKA if they fulfilled the following criteria, as 
per DKA protocol (issued in the year 1996): (a) hyperglycaemia, 
(b) ketonuria, and (c) pH less than 7.3. This protocol provided 
guidelines on parameter monitoring, investigations, and 
therapeutic intervention. Instructions on fluid balance, insulin 
infusion rates and potassium supplements were given. The 
protocol also mentioned indications for antibiotics and sodium 
bicarbonate use. 
The aim of this audit was to analyse the protocol used in 
the management of patients admitted with DKA to a University 
Teaching Hospital. This would then help in the development of 
new guidelines with consequent improved patient care.
Method
The subjects studied were adult patients (≥ fourteen years 
of age) admitted to SLH with ‘DKA’ between 14th August 2004 
and 14th August 2005 as per Admission book at the Accident 
and Emergency (A&E) Department.  Data of defined criteria 
were obtained from patients’ medical records in line with Data 
Protection Act and analysed according to a preset proforma. 
All data were recorded on Microsoft Excel spreadsheet. 
Analysis of data was then performed using SPSS version 14.
Results
From a total of fifty six patients, forty seven files were traced, 
of which seventeen satisfied the criteria for the diagnosis of DKA. 
Out of the latter, two, considered as ‘outliers’, were excluded 
in view of their prolonged duration of stay (≥ 13.36 days). One 
of these patients was admitted with gas gangrene of the foot 
requiring urgent above-knee amputation and admission to the 
Intensive Therapy Unit. This resulted in a total length of stay of 
37 days. The hospital stay of the second patient was complicated 
by a seizure; ultimately the patient discharged against medical 
advice 15 days post-admission.
In the population studied (15 patients) the mean age was 
28 years with a male predominance of 60% (n=9). Ten patients 
suffered from Type 1 DM, two patients suffered from Type 2 DM 
whilst the other three were newly diagnosed with the disease.
Out of the ten patients with Type 1 DM, nine patients were on 
a fixed insulin regime whilst one patient was on a combination of 
subcutaneous insulin and an oral hypoglycaemic agent (OHA), 
metformin. One of the Type 2 DM patients was on glibenclamide 
whilst the other was on a fixed insulin regime. 
Reasons for DKA
Compliance to insulin was documented in nine out of eleven 
patients. Three patients were documented to have missed their 
fixed insulin regime, Table 1. 
Investigations
The majority of patients (80%, n=12) had all the necessary 
investigations performed. On admission, two patients did not 
have their random blood glucose (RBG) checked, whilst four 
patients did not have their temperature recorded. Only one 
patient (14 year old) did not have a chest X-ray performed on 
admission. Other results are shown in Table 2. 
Table : Reasons for admission with Diabetic 
ketoacidosis as documented on the patients’ notes
Reason
Frequency 
(n)
Gastroenteritis 6
No reason documented 5
Upper respiratory tract infection 3
Incision of abscess 1
Investigation Mean 95% Confidence Interval
Arterial blood gases 
 - pH 7.16 (7.11, 7.21)
 - pCO
2  
(mmHg) 18.55 (12.83, 24.27)
 - HCO
3
- (mmol/L) 6.92 (4.29, 9.55)
White cell count ( x 109/L) 17.26 (13.28, 21.30)
Creatinine (µmol/L) 111.93 (91.67, 132.20)
Random blood glucose (mmol/L) 28.85 (23.44, 34.26)
Ketonuria 3.67 (3.20, 4.14)
Table 2: The mean values and 95% confidence intervals for the investigations taken on admission. In view of 
the small sample size it was preferable to use bedside blood glucose monitoring (BGM) reading in lieu of random 
blood glucose (RBG) readings where the latter were missing rather than treating them simply as missing data. All 
continuous variables were tested for normality using Q-Q Plots and were found to be within acceptable limits
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Serum amylase
According to the DKA protocol, patients who have abdominal 
pain should have their serum amylase checked.  Five patients 
admitted with DKA had their amylase checked on admission. 
Of these, four subjects had abdominal pain whilst one was pain 
free. All patients who complained of abdominal pain had their 
amylase checked. 
White cell count and temperature
Out of a total of fifteen patients, twelve were started on 
antibiotics. Of these, ten had a high white cell count (taken 
as >11 x 109 /L) whilst two patients had a normal white cell 
count. All patients with a high white cell count were started on 
antibiotics. 
Four patients did not have their temperature recorded on 
admission. Two patients were febrile (>37°C) and both were 
started on antibiotics.
Arterial blood gases (ABGs)
According to the DKA protocol ABGs need to be taken at 
least 4 times during admission i.e. at 2, 4, 8 and 12 hours after 
admission. Eleven out of fifteen patients had at least four ABGs 
taken during admission (Table 3). Table 4 shows the frequency 
at which ABGs were taken at 2, 4, 8 and 12 hours respectively. 
Urinalysis and microscopy
During admission six patients out of fifteen had their urine 
sent for urinalysis and microscopy as requested by the DKA 
protocol.
Serial parameters
Parameters need to be taken regularly for adequate 
management of the patient with DKA. The frequency at which 
parameters were taken according to the DKA protocol is 
documented in Table 5.
Insulin administration 
Intravenous insulin infusions were administered as per 
protocol in 40.0% of the cases (n=6). None of the 15 patients 
required doubling of the dose. The frequency at which the insulin 
infusion was stopped, when bedside blood glucose monitoring 
(BGM) was less than 4, and restarted when BGM was more than 
6, was also analysed (Table 6).
Total insulin given via insulin pump according to regime 
was compared to the total insulin requested as per protocol for 
each patient using the Wilcoxon Signed Ranks Test. The actual 
mean total insulin administered was 123.33 units whilst the 
predicted mean total insulin as per protocol was 142.80 units. 
This difference was found to be significantly lower (p=0.002).
Intravenous fluid administration
In the fifteen patients studied the mean amount of fluids 
given in the first 22 hours was 7.66 litres (SD 1.55, SME 0.41). 
This difference was not statistically significant (p=0.141) when 
compared to the amount of fluids requested in the protocol.
Only two patients with a BGM <11mmol/L had their fluids 
changed to 5% dextrose in normal saline alternating with 10% 
dextrose. The other eight patients were changed to 5% dextrose 
in normal saline without alternating with 10% dextrose (Table 
7). Most of these patients were ketone free and not acidotic at 
the time, thus not requiring 10% dextrose infusion. 
Serial ABGs taken Frequency (n) Percentage (%)
None 0 0
Once 0 0
Twice 2 13.3
Three times 2 13.3
Four times or more 11 73.3
Table 3: The frequency and percentage of measurements of serial arterial blood gases (ABGs) taken during 
admission documented as once, twice, three times or four times.
Time of ABG 
(hrs)
Frequency 
(n)
Percentage 
(%)
2 9 60.0
4 8 53.3
8 8 53.3
12 8 53.3
Table 4: The frequency and percentage of 
measurements of arterial blood gases (ABGs) taken at 2, 
4, 8 and 12hrs after admission
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Potassium administration
The mean litre of intravenous fluids at which potassium 
should have been started was calculated for the 15 patients and 
was found to be 3.40. Using the Wilcoxon Signed Ranks Test, 
this was found to be significantly different from the mean litre at 
which potassium was started - 6.31 litre (p<0.001) (Figure 1).   
Further management
Sodium bicarbonate (NaHCO
3
)
Only one patient was administered NaHCO
3
 in view of a 
deteriorating pH of 7.069 despite adequate Actrapid® and fluids 
given. This patient required further monitoring at the Intensive 
Therapy Unit. 
Urinary catheter
Seven patients had a urinary catheter inserted. One of these 
patients had oliguria while in the other six patients no reason 
was documented.
Nasogastric tube 
 One patient had a nasogastric tube inserted. No reason 
was documented.
Factors influencing hours on insulin infusion 
and length of stay in hospital
The mean number of hours until the patients were changed 
to subcutaneous (sc) insulin was 51.27 hrs (SE=0.5.77 CI=39.96, 
62.58) (Figure 2). 
Correlation analysis was conducted for the total time to 
conversion to sc insulin and each of the following variables: 
pH, HCO
3
-, RBG and ketones. Backward stepwise multivariate 
regression analysis resulted in only pH having a significant 
contribution (p=0.048) (Table 8). 
The difference between the insulin administered and the 
insulin requested according to the DKA protocol per hour 
(insulin difference/hr) was also found to be significantly 
correlated with hours until changed to sc insulin (p=0.02).
The mean duration of stay in hospital was found to be 4.8 
days (SE=0.57; CI=3.68, 5.92). pH, HCO
3
-, RBG and ketones on 
admission were not found to be significantly correlated to the 
number of days in hospital (Table 9). 
Discussion
This audit attempts to analyse the entire management of 
the DKA patient, from presentation at the A & E department 
until discharge.  
The majority of patients admitted with DKA suffered from 
Type 1 DM whilst two subjects suffered from Type 2 DM. This 
shows that DKA can also affect individuals with Type 2 DM. It is 
postulated that the balance and interplay of insulin and glucagon 
predicts the type of acute hyperglycaemic emergencies (DKA 
Parameter Frequency (n) Percentage (%)
Pulse rate (1 hrly) 1 6.7
Blood pressure (2 hrly) 1 6.7
Temperature (4 hrly) 3 20.0
BGM (1 hrly) 11 73.3
Urinalysis for ketones (4 hrly) 8 53.3
Table 5: Frequency of parameters taken
BGM 
(mmol/L)
Frequency 
(n)
Frequency of 
correct action (n)
Less than 4 8 6
More than 6 3 3
Table 6: Number of times the insulin infusion was being 
stopped if bedside blood glucose monitoring (BGM) was 
<4 mmol/L and restarted when BGM was >6 mmol/L 
(frequency of correct action)
Figure 1: The range and mean of serum 
potassium level in mmol/L for each patient 
while on the DKA protocol
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and Hyperosmolar non-ketotic acidosis (HONK)), such that a 
reduction of insulin / glucagon ratio to 1:0.9 in patients with 
Type 2 DM may result in DKA instead of HONK.5
Three out of nine subjects were documented to be 
noncompliant. Compliance was not documented for the 
remaining two subjects who were on insulin prior to admission. 
Studies indicate that insulin error (with or without intercurrent 
illness) is the most common precipitating factor for DKA, 
accounting for nearly two thirds of cases (excluding those where 
DKA was the first presentation of diabetes mellitus).6
Deviations from the protocol were noted during the patients’ 
admission. Serial parameters (pulse and blood pressure) were 
taken hourly only in the Intensive Therapy Unit where intensive 
nursing care is provided.  Most of the patients had their blood 
gases taken more than four times although not at the time 
requested by the protocol. The subjects with the least number of 
arterial blood gases taken were noted to be the ones who became 
ketone free in the shortest period of time. Further, some ABG 
results may have been lost. 
Insulin was generally administered at a lower dose than the 
amount requested. This could possibly be related to physicians’ 
concerns of either hypoglycaemia or a rapid decline in blood 
glucose levels. The lower insulin doses administered via pump 
led to a delay in starting the patients on a fixed insulin regime. 
The period to conversion to sc insulin was also found to be 
associated with the degree of acidosis on admission. 
Potassium supplements were given at a later stage than 
requested by the protocol, leading to a lower mean serum 
potassium level. The delay in giving potassium supplements can 
be attributed to various reasons, mainly lack of clear instructions 
in the protocol regarding the maximum dose of potassium per 
hour that can be administered and the dose of potassium to be 
administered according to the exact serum potassium level. 
The target range of serum potassium for the DKA patient was 
also not adequately highlighted in the protocol. Other possible 
explanations for this problem include blood investigations 
either not taken or taken later then the time specified by the 
protocol, laboratory delay in issuing result and lost results. The 
majority of the patients were given the correct amount of fluid 
as requested by the protocol. 
The mean duration of stay for the patients analysed was 
4.8 days. This is comparable to the length of stay in other 
countries.7
Definition of DKA in the protocol is very restrictive with 
no mention of bicarbonate, anion gap and serum osmolality. 
Variability was revealed in the time spent to give one litre 
saline running, varying from fifteen minutes to one hour. The 
protocol does not state at which point one should be switched 
to a fixed insulin regime, leaving this to the discretion of the 
attending physician.
This audit has its limitations. The population studied 
was small, some files could not be traced and some blood 
investigations had been lost. At times, it was difficult to 
interpret the observation and fluid-balance charts mainly 
due to inadequate/unclear documentation. Even the patients’ 
notes were sometimes not exhaustive and lacked important 
information about patients’ management.
Nonetheless, this audit has helped to identify some of 
the problems encountered in the management of the patient 
admitted with DKA. 
The new DKA protocol that has recently been introduced 
addresses most of the previous limitations. Thus, the 
definition of DKA is more exhaustive with inclusion of the 
level of bicarbonate and hyperglycaemia. Clearer and simpler 
instructions are provided for the rate and type of intravenous 
fluids to be given. Potassium supplementation is changed to 
BGM (mmol/L) Frequency 
(n)
Frequency of 
correct action (n)
Less than 11 14 10
More than 11 11 2
Table 7: Frequency of the change in intravenous 
fluids to 5% dextrose in normal saline when bedside 
blood glucose monitoring (BGM) <11mmol/L and the 
frequency at which fluids were changed back to normal 
saline when BGM rose back to >11mmol/L (frequency of 
correct action)
Variable Correlation p value
pH -0.517 0.048
HCO
3
- (mmol/L)  0.505 0.055
Random blood glucose (mmol/L)  0.413 0.126
Ketones -0.103 0.714
Table 8: p values and correlation coefficients for hours until switching the patient to sc insulin and each of 
the above variables.  Statistically significant values are shown in bold
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potassium required per litre instead of potassium per hour, 
and guidelines are provided to indicate when one should switch 
the patient to a fixed insulin regime and consequently stop the 
DKA protocol.
In addition, the new protocol aims at improving patient 
monitoring by providing a data monitoring sheet, resulting in 
facilitated documentation. The protocol also includes allocation 
of a nurse for each patient, regular reviews by a medical officer 
and involvement of the emergency lab. 
The new protocol will hopefully reduce the period to 
conversion to a fixed insulin regime and give more confidence to 
the attending physician with regards to decision making in the 
management of the DKA patient.  It also provides nursing staff 
with increasing awareness regarding the serious implications 
of this diabetic emergency. 
Table 9: p values and correlation coefficients for number of days in hospital and each of the above variables
Variable Correlation p value
pH -0.046 0.870
HCO
3
- (mmol/L) -0.265 0.339
Random Blood Glucose (mmol/L)  0.296 0.293
Ketones -0.098 0.728
Figure 2: Time distribution for commencement 
of the DKA protocol to conversion to 
subcutaneous (sc) insulin.
Many episodes of DKA can be prevented through better 
patient education. Sick-day management should be reviewed 
periodically with all patients and include specific information 
on (a) when to contact the health care provider, (b) blood 
glucose goals and use of supplemental short-acting insulin 
during illness, (c) means to suppress fever and treat infection, 
and (d) initiation of an easily digestible liquid diet containing 
carbohydrates and salt. Most importantly, the patient should 
be advised to never discontinue insulin and seek professional 
advice early in the course of the illness.
Conclusion
In this audit we have analysed the DKA protocol that had 
been used at SLH for several years with the aim of improving 
the ultimate management of the patient admitted with DKA. 
The authors shall reaudit the new protocol in the forthcoming 
months.
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